APO Research
Talk to an analyst

APO RESEARCH · REPORT

Natamycin

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Selected research

Market Analysis & Forecast

Global Natamycin Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchNatamycin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Natamycin Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Natamycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Natamycin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Natamycin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.

Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.

North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.

Read the full market overview

In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.

This report presents an overview of global market for Natamycin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Natamycin, also provides the sales of main regions and countries. Of the upcoming market potential for Natamycin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Natamycin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Natamycin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Natamycin sales, projected growth trends, production technology, application and end-user industry.

Natamycin Segment by Company

Danisco

DSM

VGP

Handary

AMTECH BIOTECH

Silver-Elephant

Lanzhou Weiri

Langfang Meihua

Zhengzhou New Frey

Chihon

Jiaozuo Joincare

Beijing Oriental Rada

Pucheng Lifecome

Natamycin Segment by Type

Glucose-based

Lactose-based

Sodium chloride-based

Natamycin Segment by Application

Food

Medical

Others

Natamycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Natamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natamycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Natamycin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natamycin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Natamycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Glucose-based Major Manufacturers Table 3. Lactose-based Major Manufacturers Table 4. Sodium chloride-based Major Manufacturers Table 5. Global Natamycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Food Major Manufacturers Table 7. Medical Major Manufacturers Table 8. Others Major Manufacturers Table 9. Natamycin Industry Trends Table 10. Natamycin Industry Drivers Table 11. Natamycin Industry Opportunities and Challenges Table 12. Natamycin Industry Restraints Table 13. Global Natamycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Natamycin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Natamycin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Natamycin Revenue Market Share by Region (2021-2026) Table 17. Global Natamycin Revenue Market Share by Region (2027-2032) Table 18. Global Natamycin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (MT) Table 19. Global Natamycin Sales by Region (2021-2026) & (MT) Table 20. Global Natamycin Sales by Region (2027-2032) & (MT) Table 21. Global Natamycin Sales Market Share by Region (2021-2026) Table 22. Global Natamycin Sales Market Share by Region (2027-2032) Table 23. Global Natamycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Natamycin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Natamycin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Natamycin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Natamycin Sales Price (USD/MT) of Manufacturers (2021-2026) Table 28. Global Natamycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Natamycin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Natamycin Manufacturers, Product Type & Application Table 31. Global Natamycin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Natamycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Natamycin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Natamycin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Natamycin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Natamycin Revenue Market Share by Type (2021-2026) Table 38. Global Natamycin Revenue Market Share by Type (2027-2032) Table 39. Global Natamycin Sales by Type 2021 VS 2025 VS 2032 (MT) Table 40. Global Natamycin Sales by Type (2021-2026) & (MT) Table 41. Global Natamycin Sales by Type (2027-2032) & (MT) Table 42. Global Natamycin Sales Market Share by Type (2021-2026) Table 43. Global Natamycin Sales Market Share by Type (2027-2032) Table 44. Global Natamycin Price by Type (2021-2026) & (USD/MT) Table 45. Global Natamycin Price by Type (2027-2032) & (USD/MT) Table 46. Global Natamycin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Natamycin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Natamycin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Natamycin Revenue Market Share by Application (2021-2026) Table 50. Global Natamycin Revenue Market Share by Application (2027-2032) Table 51. Global Natamycin Sales by Application 2021 VS 2025 VS 2032 (MT) Table 52. Global Natamycin Sales by Application (2021-2026) & (MT) Table 53. Global Natamycin Sales by Application (2027-2032) & (MT) Table 54. Global Natamycin Sales Market Share by Application (2021-2026) Table 55. Global Natamycin Sales Market Share by Application (2027-2032) Table 56. Global Natamycin Price by Application (2021-2026) & (USD/MT) Table 57. Global Natamycin Price by Application (2027-2032) & (USD/MT) Table 58. Danisco Company Information Table 59. Danisco Business Overview Table 60. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 61. Danisco Natamycin Product Portfolio Table 62. Danisco Recent Development Table 63. DSM Company Information Table 64. DSM Business Overview Table 65. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 66. DSM Natamycin Product Portfolio Table 67. DSM Recent Development Table 68. VGP Company Information Table 69. VGP Business Overview Table 70. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 71. VGP Natamycin Product Portfolio Table 72. VGP Recent Development Table 73. Handary Company Information Table 74. Handary Business Overview Table 75. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 76. Handary Natamycin Product Portfolio Table 77. Handary Recent Development Table 78. AMTECH BIOTECH Company Information Table 79. AMTECH BIOTECH Business Overview Table 80. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 81. AMTECH BIOTECH Natamycin Product Portfolio Table 82. AMTECH BIOTECH Recent Development Table 83. Silver-Elephant Company Information Table 84. Silver-Elephant Business Overview Table 85. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 86. Silver-Elephant Natamycin Product Portfolio Table 87. Silver-Elephant Recent Development Table 88. Lanzhou Weiri Company Information Table 89. Lanzhou Weiri Business Overview Table 90. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 91. Lanzhou Weiri Natamycin Product Portfolio Table 92. Lanzhou Weiri Recent Development Table 93. Langfang Meihua Company Information Table 94. Langfang Meihua Business Overview Table 95. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 96. Langfang Meihua Natamycin Product Portfolio Table 97. Langfang Meihua Recent Development Table 98. Zhengzhou New Frey Company Information Table 99. Zhengzhou New Frey Business Overview Table 100. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 101. Zhengzhou New Frey Natamycin Product Portfolio Table 102. Zhengzhou New Frey Recent Development Table 103. Chihon Company Information Table 104. Chihon Business Overview Table 105. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 106. Chihon Natamycin Product Portfolio Table 107. Chihon Recent Development Table 108. Jiaozuo Joincare Company Information Table 109. Jiaozuo Joincare Business Overview Table 110. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 111. Jiaozuo Joincare Natamycin Product Portfolio Table 112. Jiaozuo Joincare Recent Development Table 113. Beijing Oriental Rada Company Information Table 114. Beijing Oriental Rada Business Overview Table 115. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 116. Beijing Oriental Rada Natamycin Product Portfolio Table 117. Beijing Oriental Rada Recent Development Table 118. Pucheng Lifecome Company Information Table 119. Pucheng Lifecome Business Overview Table 120. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 121. Pucheng Lifecome Natamycin Product Portfolio Table 122. Pucheng Lifecome Recent Development Table 123. North America Natamycin Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Natamycin Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Natamycin Sales by Type (2021-2026) & (MT) Table 126. North America Natamycin Sales by Type (2027-2032) & (MT) Table 127. North America Natamycin Sales Price by Type (2021-2026) & (USD/MT) Table 128. North America Natamycin Sales Price by Type (2027-2032) & (USD/MT) Table 129. North America Natamycin Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Natamycin Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Natamycin Sales by Application (2021-2026) & (MT) Table 132. North America Natamycin Sales by Application (2027-2032) & (MT) Table 133. North America Natamycin Sales Price by Application (2021-2026) & (USD/MT) Table 134. North America Natamycin Sales Price by Application (2027-2032) & (USD/MT) Table 135. North America Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Natamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Natamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Natamycin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 139. North America Natamycin Sales by Country (2021-2026) & (MT) Table 140. North America Natamycin Sales by Country (2027-2032) & (MT) Table 141. North America Natamycin Sales Price by Country (2021-2026) & (USD/MT) Table 142. North America Natamycin Sales Price by Country (2027-2032) & (USD/MT) Table 143. United States Natamycin Revenue (2021-2032) & (US$ Million) Table 144. Canada Natamycin Revenue (2021-2032) & (US$ Million) Table 145. Mexico Natamycin Revenue (2021-2032) & (US$ Million) Table 146. Europe Natamycin Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Natamycin Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Natamycin Sales by Type (2021-2026) & (MT) Table 149. Europe Natamycin Sales by Type (2027-2032) & (MT) Table 150. Europe Natamycin Sales Price by Type (2021-2026) & (USD/MT) Table 151. Europe Natamycin Sales Price by Type (2027-2032) & (USD/MT) Table 152. Europe Natamycin Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Natamycin Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Natamycin Sales by Application (2021-2026) & (MT) Table 155. Europe Natamycin Sales by Application (2027-2032) & (MT) Table 156. Europe Natamycin Sales Price by Application (2021-2026) & (USD/MT) Table 157. Europe Natamycin Sales Price by Application (2027-2032) & (USD/MT) Table 158. Europe Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Natamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Natamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Natamycin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 162. Europe Natamycin Sales by Country (2021-2026) & (MT) Table 163. Europe Natamycin Sales by Country (2027-2032) & (MT) Table 164. Europe Natamycin Sales Price by Country (2021-2026) & (USD/MT) Table 165. Europe Natamycin Sales Price by Country (2027-2032) & (USD/MT) Table 166. Germany Natamycin Revenue (2021-2032) & (US$ Million) Table 167. France Natamycin Revenue (2021-2032) & (US$ Million) Table 168. U.K. Natamycin Revenue (2021-2032) & (US$ Million) Table 169. Italy Natamycin Revenue (2021-2032) & (US$ Million) Table 170. Russia Natamycin Revenue (2021-2032) & (US$ Million) Table 171. Spain Natamycin Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Natamycin Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Natamycin Revenue (2021-2032) & (US$ Million) Table 174. Sweden Natamycin Revenue (2021-2032) & (US$ Million) Table 175. Poland Natamycin Revenue (2021-2032) & (US$ Million) Table 176. China Natamycin Revenue by Type (2021-2026) & (US$ Million) Table 177. China Natamycin Revenue by Type (2027-2032) & (US$ Million) Table 178. China Natamycin Sales by Type (2021-2026) & (MT) Table 179. China Natamycin Sales by Type (2027-2032) & (MT) Table 180. China Natamycin Sales Price by Type (2021-2026) & (USD/MT) Table 181. China Natamycin Sales Price by Type (2027-2032) & (USD/MT) Table 182. China Natamycin Revenue by Application (2021-2026) & (US$ Million) Table 183. China Natamycin Revenue by Application (2027-2032) & (US$ Million) Table 184. China Natamycin Sales by Application (2021-2026) & (MT) Table 185. China Natamycin Sales by Application (2027-2032) & (MT) Table 186. China Natamycin Sales Price by Application (2021-2026) & (USD/MT) Table 187. China Natamycin Sales Price by Application (2027-2032) & (USD/MT) Table 188. Asia Natamycin Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Natamycin Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Natamycin Sales by Type (2021-2026) & (MT) Table 191. Asia Natamycin Sales by Type (2027-2032) & (MT) Table 192. Asia Natamycin Sales Price by Type (2021-2026) & (USD/MT) Table 193. Asia Natamycin Sales Price by Type (2027-2032) & (USD/MT) Table 194. Asia Natamycin Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Natamycin Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Natamycin Sales by Application (2021-2026) & (MT) Table 197. Asia Natamycin Sales by Application (2027-2032) & (MT) Table 198. Asia Natamycin Sales Price by Application (2021-2026) & (USD/MT) Table 199. Asia Natamycin Sales Price by Application (2027-2032) & (USD/MT) Table 200. Asia Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Natamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Natamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Natamycin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 204. Asia Natamycin Sales by Country (2021-2026) & (MT) Table 205. Asia Natamycin Sales by Country (2027-2032) & (MT) Table 206. Asia Natamycin Sales Price by Country (2021-2026) & (USD/MT) Table 207. Asia Natamycin Sales Price by Country (2027-2032) & (USD/MT) Table 208. Japan Natamycin Revenue (2021-2032) & (US$ Million) Table 209. South Korea Natamycin Revenue (2021-2032) & (US$ Million) Table 210. India Natamycin Revenue (2021-2032) & (US$ Million) Table 211. Australia Natamycin Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Natamycin Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Natamycin Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Natamycin Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Natamycin Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Natamycin Sales by Type (2021-2026) & (MT) Table 217. SAMEA Natamycin Sales by Type (2027-2032) & (MT) Table 218. SAMEA Natamycin Sales Price by Type (2021-2026) & (USD/MT) Table 219. SAMEA Natamycin Sales Price by Type (2027-2032) & (USD/MT) Table 220. SAMEA Natamycin Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Natamycin Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Natamycin Sales by Application (2021-2026) & (MT) Table 223. SAMEA Natamycin Sales by Application (2027-2032) & (MT) Table 224. SAMEA Natamycin Sales Price by Application (2021-2026) & (USD/MT) Table 225. SAMEA Natamycin Sales Price by Application (2027-2032) & (USD/MT) Table 226. SAMEA Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Natamycin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Natamycin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Natamycin Sales by Country (2021 VS 2025 VS 2032) & (MT) Table 230. SAMEA Natamycin Sales by Country (2021-2026) & (MT) Table 231. SAMEA Natamycin Sales by Country (2027-2032) & (MT) Table 232. SAMEA Natamycin Sales Price by Country (2021-2026) & (USD/MT) Table 233. SAMEA Natamycin Sales Price by Country (2027-2032) & (USD/MT) Table 234. Brazil Natamycin Revenue (2021-2032) & (US$ Million) Table 235. Argentina Natamycin Revenue (2021-2032) & (US$ Million) Table 236. Chile Natamycin Revenue (2021-2032) & (US$ Million) Table 237. Colombia Natamycin Revenue (2021-2032) & (US$ Million) Table 238. Peru Natamycin Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Natamycin Revenue (2021-2032) & (US$ Million) Table 240. Israel Natamycin Revenue (2021-2032) & (US$ Million) Table 241. UAE Natamycin Revenue (2021-2032) & (US$ Million) Table 242. Turkey Natamycin Revenue (2021-2032) & (US$ Million) Table 243. Iran Natamycin Revenue (2021-2032) & (US$ Million) Table 244. Egypt Natamycin Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Natamycin Distributors List Table 248. Natamycin Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Natamycin Image Figure 2. Global Natamycin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Natamycin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Glucose-based Image Figure 5. Lactose-based Image Figure 6. Sodium chloride-based Image Figure 7. Global Natamycin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Natamycin Market Size Share 2021 VS 2025 VS 2032 Figure 9. Food Image Figure 10. Medical Image Figure 11. Others Image Figure 12. Global Natamycin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Natamycin Revenue (2021-2032) & (US$ Million) Figure 14. Global Natamycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Natamycin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Natamycin Revenue Market Share by Region (2021-2032) Figure 17. Global Natamycin Sales (2021-2032) & (MT) Figure 18. Global Natamycin Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 19. Global Natamycin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Natamycin Sales YoY (2021-2032) & (MT) Figure 21. Europe Natamycin Sales YoY (2021-2032) & (MT) Figure 22. China Natamycin Sales YoY (2021-2032) & (MT) Figure 23. Asia (Excluding China) Natamycin Sales YoY (2021-2032) & (MT) Figure 24. South America, Middle East and Africa Natamycin Sales YoY (2021-2032) & (MT) Figure 25. Global Natamycin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Natamycin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Natamycin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Natamycin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Natamycin Revenue Market Share by Type (2021-2032) Figure 31. Global Natamycin Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 32. Global Natamycin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Natamycin Sales Market Share by Type (2021-2032) Figure 34. Global Natamycin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Natamycin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Natamycin Revenue Market Share by Application (2021-2032) Figure 37. Global Natamycin Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 38. Global Natamycin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Natamycin Sales Market Share by Application (2021-2032) Figure 40. North America Natamycin Revenue Share by Type (2021-2032) Figure 41. North America Natamycin Sales Share by Type (2021-2032) Figure 42. North America Natamycin Revenue Share by Application (2021-2032) Figure 43. North America Natamycin Sales Share by Application (2021-2032) Figure 44. North America Natamycin Revenue Share by Country (2021-2032) Figure 45. North America Natamycin Sales Share by Country (2021-2032) Figure 46. Europe Natamycin Revenue Share by Type (2021-2032) Figure 47. Europe Natamycin Sales Share by Type (2021-2032) Figure 48. Europe Natamycin Revenue Share by Application (2021-2032) Figure 49. Europe Natamycin Sales Share by Application (2021-2032) Figure 50. Europe Natamycin Revenue Share by Country (2021-2032) Figure 51. Europe Natamycin Sales Share by Country (2021-2032) Figure 52. China Natamycin Revenue Share by Type (2021-2032) Figure 53. China Natamycin Sales Share by Type (2021-2032) Figure 54. China Natamycin Revenue Share by Application (2021-2032) Figure 55. China Natamycin Sales Share by Application (2021-2032) Figure 56. Asia Natamycin Revenue Share by Type (2021-2032) Figure 57. Asia Natamycin Sales Share by Type (2021-2032) Figure 58. Asia Natamycin Revenue Share by Application (2021-2032) Figure 59. Asia Natamycin Sales Share by Application (2021-2032) Figure 60. Asia Natamycin Revenue Share by Country (2021-2032) Figure 61. Asia Natamycin Sales Share by Country (2021-2032) Figure 62. SAMEA Natamycin Revenue Share by Type (2021-2032) Figure 63. SAMEA Natamycin Sales Share by Type (2021-2032) Figure 64. SAMEA Natamycin Revenue Share by Application (2021-2032) Figure 65. SAMEA Natamycin Sales Share by Application (2021-2032) Figure 66. SAMEA Natamycin Revenue Share by Country (2021-2032) Figure 67. SAMEA Natamycin Sales Share by Country (2021-2032) Figure 68. Natamycin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Natamycin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Glucose-based
  • Lactose-based
  • Sodium chloride-based
Applications
  • Food
  • Medical
  • Others
Companies covered
  • Danisco
  • DSM
  • VGP
  • Handary
  • AMTECH BIOTECH
  • Silver-Elephant
  • Lanzhou Weiri
  • Langfang Meihua
  • Zhengzhou New Frey
  • Chihon
  • Jiaozuo Joincare
  • Beijing Oriental Rada
  • Pucheng Lifecome

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Natamycin Market by Type
  3. 1.2.1 Global Natamycin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Glucose-based
  5. 1.2.3 Lactose-based
  6. 1.2.4 Sodium chloride-based
  7. 1.3 Natamycin Market by Application
  8. 1.3.1 Global Natamycin Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Food
  10. 1.3.3 Medical
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Natamycin Market Dynamics
  1. 2.1 Natamycin Industry Trends
  2. 2.2 Natamycin Industry Drivers
  3. 2.3 Natamycin Industry Opportunities and Challenges
  4. 2.4 Natamycin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Natamycin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Natamycin Revenue by Region
  3. 3.2.1 Global Natamycin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Natamycin Revenue by Region (2021-2026)
  5. 3.2.3 Global Natamycin Revenue by Region (2027-2032)
  6. 3.2.4 Global Natamycin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Natamycin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Natamycin Sales by Region
  9. 3.4.1 Global Natamycin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Natamycin Sales by Region (2021-2026)
  11. 3.4.3 Global Natamycin Sales by Region (2027-2032)
  12. 3.4.4 Global Natamycin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Natamycin Revenue by Manufacturers
  2. 4.1.1 Global Natamycin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Natamycin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Natamycin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Natamycin Sales by Manufacturers
  6. 4.2.1 Global Natamycin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Natamycin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Natamycin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Natamycin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Natamycin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Natamycin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Natamycin Manufacturers, Product Type & Application
  13. 4.7 Global Natamycin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Natamycin Market CR5 and HHI
  16. 4.8.2 2025 Natamycin Tier 1, Tier 2, and Tier 3
5 Natamycin Market by Type
  1. 5.1 Global Natamycin Revenue by Type
  2. 5.1.1 Global Natamycin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Natamycin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Natamycin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Natamycin Sales by Type
  6. 5.2.1 Global Natamycin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Natamycin Sales by Type (2021-2032) & (MT)
  8. 5.2.3 Global Natamycin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Natamycin Price by Type
6 Natamycin Market by Application
  1. 6.1 Global Natamycin Revenue by Application
  2. 6.1.1 Global Natamycin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Natamycin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Natamycin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Natamycin Sales by Application
  6. 6.2.1 Global Natamycin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Natamycin Sales by Application (2021-2032) & (MT)
  8. 6.2.3 Global Natamycin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Natamycin Price by Application
7 Company Profiles
  1. 7.1 Danisco
  2. 7.1.1 Danisco Company Information
  3. 7.1.2 Danisco Business Overview
  4. 7.1.3 Danisco Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Danisco Natamycin Product Portfolio
  6. 7.1.5 Danisco Recent Developments
  7. 7.2 DSM
  8. 7.2.1 DSM Company Information
  9. 7.2.2 DSM Business Overview
  10. 7.2.3 DSM Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 DSM Natamycin Product Portfolio
  12. 7.2.5 DSM Recent Developments
  13. 7.3 VGP
  14. 7.3.1 VGP Company Information
  15. 7.3.2 VGP Business Overview
  16. 7.3.3 VGP Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 VGP Natamycin Product Portfolio
  18. 7.3.5 VGP Recent Developments
  19. 7.4 Handary
  20. 7.4.1 Handary Company Information
  21. 7.4.2 Handary Business Overview
  22. 7.4.3 Handary Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Handary Natamycin Product Portfolio
  24. 7.4.5 Handary Recent Developments
  25. 7.5 AMTECH BIOTECH
  26. 7.5.1 AMTECH BIOTECH Company Information
  27. 7.5.2 AMTECH BIOTECH Business Overview
  28. 7.5.3 AMTECH BIOTECH Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AMTECH BIOTECH Natamycin Product Portfolio
  30. 7.5.5 AMTECH BIOTECH Recent Developments
  31. 7.6 Silver-Elephant
  32. 7.6.1 Silver-Elephant Company Information
  33. 7.6.2 Silver-Elephant Business Overview
  34. 7.6.3 Silver-Elephant Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Silver-Elephant Natamycin Product Portfolio
  36. 7.6.5 Silver-Elephant Recent Developments
  37. 7.7 Lanzhou Weiri
  38. 7.7.1 Lanzhou Weiri Company Information
  39. 7.7.2 Lanzhou Weiri Business Overview
  40. 7.7.3 Lanzhou Weiri Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Lanzhou Weiri Natamycin Product Portfolio
  42. 7.7.5 Lanzhou Weiri Recent Developments
  43. 7.8 Langfang Meihua
  44. 7.8.1 Langfang Meihua Company Information
  45. 7.8.2 Langfang Meihua Business Overview
  46. 7.8.3 Langfang Meihua Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Langfang Meihua Natamycin Product Portfolio
  48. 7.8.5 Langfang Meihua Recent Developments
  49. 7.9 Zhengzhou New Frey
  50. 7.9.1 Zhengzhou New Frey Company Information
  51. 7.9.2 Zhengzhou New Frey Business Overview
  52. 7.9.3 Zhengzhou New Frey Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zhengzhou New Frey Natamycin Product Portfolio
  54. 7.9.5 Zhengzhou New Frey Recent Developments
  55. 7.10 Chihon
  56. 7.10.1 Chihon Company Information
  57. 7.10.2 Chihon Business Overview
  58. 7.10.3 Chihon Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chihon Natamycin Product Portfolio
  60. 7.10.5 Chihon Recent Developments
  61. 7.11 Jiaozuo Joincare
  62. 7.11.1 Jiaozuo Joincare Company Information
  63. 7.11.2 Jiaozuo Joincare Business Overview
  64. 7.11.3 Jiaozuo Joincare Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Jiaozuo Joincare Natamycin Product Portfolio
  66. 7.11.5 Jiaozuo Joincare Recent Developments
  67. 7.12 Beijing Oriental Rada
  68. 7.12.1 Beijing Oriental Rada Company Information
  69. 7.12.2 Beijing Oriental Rada Business Overview
  70. 7.12.3 Beijing Oriental Rada Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Beijing Oriental Rada Natamycin Product Portfolio
  72. 7.12.5 Beijing Oriental Rada Recent Developments
  73. 7.13 Pucheng Lifecome
  74. 7.13.1 Pucheng Lifecome Company Information
  75. 7.13.2 Pucheng Lifecome Business Overview
  76. 7.13.3 Pucheng Lifecome Natamycin Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Pucheng Lifecome Natamycin Product Portfolio
  78. 7.13.5 Pucheng Lifecome Recent Developments
8 North America
  1. 8.1 North America Natamycin Market Size by Type
  2. 8.1.1 North America Natamycin Revenue by Type (2021-2032)
  3. 8.1.2 North America Natamycin Sales by Type (2021-2032)
  4. 8.1.3 North America Natamycin Price by Type (2021-2032)
  5. 8.2 North America Natamycin Market Size by Application
  6. 8.2.1 North America Natamycin Revenue by Application (2021-2032)
  7. 8.2.2 North America Natamycin Sales by Application (2021-2032)
  8. 8.2.3 North America Natamycin Price by Application (2021-2032)
  9. 8.3 North America Natamycin Market Size by Country
  10. 8.3.1 North America Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Natamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Natamycin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Natamycin Market Size by Type
  2. 9.1.1 Europe Natamycin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Natamycin Sales by Type (2021-2032)
  4. 9.1.3 Europe Natamycin Price by Type (2021-2032)
  5. 9.2 Europe Natamycin Market Size by Application
  6. 9.2.1 Europe Natamycin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Natamycin Sales by Application (2021-2032)
  8. 9.2.3 Europe Natamycin Price by Application (2021-2032)
  9. 9.3 Europe Natamycin Market Size by Country
  10. 9.3.1 Europe Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Natamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Natamycin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Natamycin Market Size by Type
  2. 10.1.1 China Natamycin Revenue by Type (2021-2032)
  3. 10.1.2 China Natamycin Sales by Type (2021-2032)
  4. 10.1.3 China Natamycin Price by Type (2021-2032)
  5. 10.2 China Natamycin Market Size by Application
  6. 10.2.1 China Natamycin Revenue by Application (2021-2032)
  7. 10.2.2 China Natamycin Sales by Application (2021-2032)
  8. 10.2.3 China Natamycin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Natamycin Market Size by Type
  2. 11.1.1 Asia Natamycin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Natamycin Sales by Type (2021-2032)
  4. 11.1.3 Asia Natamycin Price by Type (2021-2032)
  5. 11.2 Asia Natamycin Market Size by Application
  6. 11.2.1 Asia Natamycin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Natamycin Sales by Application (2021-2032)
  8. 11.2.3 Asia Natamycin Price by Application (2021-2032)
  9. 11.3 Asia Natamycin Market Size by Country
  10. 11.3.1 Asia Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Natamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Natamycin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Natamycin Market Size by Type
  2. 12.1.1 SAMEA Natamycin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Natamycin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Natamycin Price by Type (2021-2032)
  5. 12.2 SAMEA Natamycin Market Size by Application
  6. 12.2.1 SAMEA Natamycin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Natamycin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Natamycin Price by Application (2021-2032)
  9. 12.3 SAMEA Natamycin Market Size by Country
  10. 12.3.1 SAMEA Natamycin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Natamycin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Natamycin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Natamycin Value Chain Analysis
  2. 13.1.1 Natamycin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Natamycin Production Mode & Process
  6. 13.2 Natamycin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Natamycin Distributors
  9. 13.2.3 Natamycin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst